Zynex, Inc. founded in 1996, engineers, manufactures and markets stroke rehabilitation and pain management devices. Zynex Medical is a provider of electrotherapy products for home use.
Zynex Medical's product line is fully developed, FDA cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke or debilitating and chronic pain.
Neuralink is a team of exceptionally talented people. We are creating the future of brain-machine interfaces: building devices now that will help people with paralysis and inventing new technologies that will expand our abilities, our community, and our world.
Our goal is to build a system with at least two orders of magnitude more communication channels (electrodes) than current clinically-approved devices. This system needs to be safe, it must have fully wireless communication through the skin, and it has to be ready for patients to take home and use on their own. Our device, called the Link, will be able to record from 1024 electrodes and is designed to meet these criteria.
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain disorders. NeuroMetrix, Inc. is a wholly-owned subsidiary of electroCore, Inc.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
NeuroMetrix, Inc. is a wholly-owned subsidiary of electroCore, Inc. While operating under the ownership of electroCore, NeuroMetrix will continue to provide its Quell products and services under its established brand. Our Terms of Service and Privacy Policy have been updated to reflect this change. Please review these updates to understand how this new relationship may affect your experience with us. If you have any questions, please contact us at 888-903-2673.
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.